Register

Register

Register here to subscribe to our FREE Digital Magazine and E-Newsletter. You will get unrestricted access to all news, analysis and peer-reviewed content on our website. A print subscription is also available for €180 per annum.

Register or Find out more

Menu

PRIME Journal

Search Account Actions

Already Registered?

Forgotten Password?

Register for free

Register for FREE and get unrestricted access to all news, analysis and peer-reviewed content, and create your own tailored alerts.

Register

Tags

, , , , ,

Emmanuelle Bassmann

Managing Director, In-Trend Ltd,

More articles by Emmanuelle Bassmann

  • Patrick Treacy

    I’ve been using PDT for BCC since 2003 and make up our own ALA. While Dr. Lowe has some point regarding this treatment as some of my superficial BCCs eventually required surgical excision for confirmed persistent or recurrent tumour (>8%) the treatment certainly has a role in the right hands. I like the format and information in this well balanced update article on PDT. The role of PDT-FLRS needs to be evaluated more but it is difficult to estimate tumour margins.

Analysis

Opinion

x

Send to a colleague

  • Your details

  • Your colleague's details

  • Leave a message?